News

Designation brings PharmaCielo a step closer to EU-GMP compliance; supports continued expansion of medicinal-grade extract exports GACP certification is based on WHO guidelines for quality assurance and control of herbal medicines TORONTO, Canada and RIONEGRO, Colombia (November 25, 2020) – PharmaCielo Ltd. (“PharmaCielo” or the

TORONTO, Ontario (November 23, 2020) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTCQX: PCLOF) is pleased to announce the closing of its previously announced private placement of units ("Units") of the Company for gross proceeds of $10.0 million. “The closing of this offering further strengthens the Company’s balance sheet

TORONTO, Canada and MEXICO CITY, Mexico (November 19, 2020) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTCQX: PCLOF) and MINO Labs S.A. de C.V. (“MINO Labs”), the founders of PharmaCielo S.A. de C.V. (“PharmaCielo Mexico”), congratulate Mexican Senate members for advancing the much-needed cannabis legislation and subsequent reform

Including Initial Shipment, PharmaCielo will deliver total 1,000 kg of product to Customer – with revenue and cash flow reflected in 2020; interim 2021 sales agreement reached for continued Q1 volume and revenue. Relationship adds U.K. and additional E.U. exposure to PharmaCielo’s current commercial relationships

TORONTO, Canada (November 16, 2020) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced today that it will host a conference call on Monday, November

First harvest cycle of high-THC cultivars expected to yield more than 10 tonnes of dry flower for extract processing Extracts from six psychoactive cultivars part of Company’s expanded product portfolio announced in mid-September Company holds Government approval for commercial export of high-THC extracts TORONTO, Canada

Not for distribution to United States newswire services or for dissemination in the United States TORONTO, Ontario (November 3, 2020) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTCQX: PCLOF) is pleased to announce that, due to high demand, it has increased the size of its previously

​​​​​​​​Not for distribution to United States newswire services or for dissemination in the United States TORONTO, Ontario (November 2, 2020) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTCQX: PCLOF) is pleased to announce that Marc Lustig, the highly successful cannabis industry leader with expertise in

TORONTO and RIONEGRO, Colombia (September 22, 2020) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., is very pleased to announce that the Colombian  Intersectoral Commission for Strategic

New offerings allow PharmaCielo to respond to market demand with expanded product range Extracts derived from proprietary cultivars and produced internally at 30,000+ sq. ft. processing and extraction facility Independent analytical verification of unique medicinal profile and high quality Current inventories support immediate new product